The market opened on a negative note this Friday, with the Sensex down by 800 points (1.08%) at 78,936.56 and the Nifty 50 at 23,960.55, down 286 points (1.18%). This downward movement comes after a period of positive momentum in the market, indicating investors’ cautious approach amid varied global indicators. Today’s decline can be attributed to growing concerns over global economic slowdown signals and profit-booking after the recent rally. Additionally, investors closely monitor the ongoing trade tensions between major economies and their potential impact on the international markets.
Stocks to Buy Today
Here are the curated stocks you may track in today’s trading session:
Sonata Software Ltd. [NSE:SONATSOFTW]
Sonata Software provides IT services and solutions across the United States, Europe, the Middle East, Asia, India, and Australia. The company specializes in power platform services, data transformation, artificial intelligence, cloud solutions, and data modernization services.
In a significant development, the company announced in a regulatory filing on April 16, 2025, that revenue estimates for Q4 2024-25 from its largest client are likely to be lower than anticipated. This is expected to result in lower revenue from its international business for the quarter than previously communicated during the analyst/investor call held on February 6, 2025.
During the February 2025 earnings call, CFO Jagannathan CN had indicated that the company expected about 2.5% to 3.5% degrowth in the next quarter, including seasonal impact.
Key details of Sonata Software stocks:
| Parameter | Value |
| Closing Price (as of April 24, 2025) | ₹355.50 |
| Trading Volume | 2,644,382 |
| Company Type | Smallcap |
| Market Cap | ₹9,869 crores |
| Beta | 1.00 |
Apar Industries Ltd. [NSE:APARINDS]
Apar Industries is a leading manufacturer of conductors, transformer oils, specialty oils, and cables. The company operates across three primary segments: conductors, transformer & specialty oils, and power & telecom cables.
Apar Industries has demonstrated strong financial performance in recent quarters, with a substantial increase in export volumes, particularly in its conductor and oil segments. The company’s strategic focus on high-margin specialty products and increased investments in manufacturing capacity have strengthened its market position.
Key details of Apar Industries stocks:
| Parameter | Value |
| Closing Price (as of April 24, 2025) | ₹5,504.00 |
| Trading Volume | 49,407 |
| Company Type | Smallcap |
| Market Cap | ₹21,731 crores |
| Beta | 0.77 |
Happiest Minds Technologies Ltd. [NSE:HAPPSTMNDS]
Happiest Minds Technologies specializes in digital transformation, providing IT services focused on disruptive technologies such as cloud computing, Internet of Things (IoT), security, and analytics.
In a significant development, Happiest Minds Technologies has announced the launch of Investment Companion, a generative AI investor solution, in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. This strategic move enables Happiest Minds customers to leverage the productive and trusted Azure cloud platform with streamlined deployment and management.
Investment Companion is described as a comprehensive investor relations knowledge management system that extracts, processes, and prioritizes content from multiple sources. The solution provides interactive, multimedia-rich responses via a chat interface with integrated feedback, enhancing the accessibility and usability of critical information.
Key details of Happiest Minds Technologies stocks:
| Parameter | Value |
| Closing Price (as of April 24, 2025) | ₹599.95 |
| Trading Volume | 130,765 |
| Company Type | Smallcap |
| Market Cap | ₹8,912 crores |
| Beta | 0.53 |
Natco Pharma Ltd. [NSE:NATCOPHARM]
Natco Pharma is engaged in manufacturing and marketing pharmaceutical products. The company’s business segments include active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and job work.
In a recent development, Natco Pharma has issued a clarification regarding the legal proceedings on its Risdiplam launch in India. While the Delhi High Court initially denied Roche’s plea for an injunction against Natco on March 24, 2025, Roche has appealed the decision, and the Appellate Bench has directed that the status quo be maintained. Natco has stated its intention to launch the drug only after receiving clarity from the Appellate Bench, which is expected shortly.
Subject to favorable legal outcomes, the company has decided to price Risdiplam at ₹15,900 MRP and plans to offer discounts to certain deserving patients through its patient access program. This case represents Natco’s ongoing efforts to make critical medications more accessible in the Indian market.
Key details of Natco Pharma stocks:
| Parameter | Value |
| Closing Price (as of April 24, 2025) | ₹902.85 |
| Trading Volume | 1,649,971 |
| Company Type | Smallcap |
| Market Cap | ₹15,673 crores |
| Beta | 0.84 |
Conclusion
With the market showing negative movement today after breaking its seven-day winning streak yesterday, these stocks present interesting tracking opportunities for market participants. However, it’s important to note that market conditions remain subject to rapid changes influenced by global economic factors, geopolitical developments, and corporate performance reports.
Before making any investment decisions regarding the mentioned stocks or others, it’s advisable to conduct a thorough technical analysis using multiple charts and indicators. For long-term investors, evaluating company fundamentals, financial health, and management quality remains essential for informed decision-making.
Just starting out with investing? Begin your stock market journey by opening a Demat Account with Torus Digital today.
